Name | blinatuMoMab |
---|
Description | Blinatumomab (Anatumomab) is a bispecific monoclonal antibody which can specifically targets the CD19 antigen present on B cells. Blinatumomab can be used for the research of acute lymphoblastic leukemia[1]. |
---|---|
Related Catalog | |
References |
No Any Chemical & Physical Properties |